Literature DB >> 12684811

Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine.

Birgitta Kütting1, Hans Drexler.   

Abstract

OBJECTIVES: This study attempts to assess the evidence of the generally recommended three-step programme of skin protection in the prevention of occupational skin disease.
METHODS: The following clinical questions, representative of critical appraisal of this preventive measurement, were generated: (1) Can a skincare regimen effectively reduce or eliminate work-related poor skin conditions? (2) Do protective creams prevent harmful substances from penetrating and adhering to the skin? (3) Is the differentiation between pre-exposure and post-exposure products justified by reliable data? Answers were generated according to the method used in evidence-based medicine by searching the literature, critically appraising the results and applying the results to the clinical questions. For our search we decided to use PubMed as the most convenient access to Medline and because, in contrast to other databases, this access is available free of charge.
RESULTS: To investigate the efficacy of barrier creams as pre-exposure skin protectors various in vitro and in vivo test methods have been developed. Over the past years the test techniques have been improved in order to adopt a real workplace situation. Efforts for standardisation of evaluation criteria have been made, too. Nevertheless, there is a lack of placebo-controlled, randomised clinical trials evaluating the benefit of these products in the prevention of occupational contact dermatitis under real workplace conditions. The literature data are conflicting; some publications report on the positive aspects of skin protection, whereas others stress the negative ones.
CONCLUSION: Not enough data have been accumulated for one to prove the benefit of skin protection measures under real workplace condition. Up to now, it is almost unclear if the various in vitro and in vivo methods used are suitable to simulate real workplace conditions and if these test results can be related to real occupational exposure. For the evidence-based recommendation of skin protection, further studies, especially under daily working conditions evaluating the contribution of each single element of skincare programme (products, frequency of application and education programme) are needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684811     DOI: 10.1007/s00420-003-0437-6

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  56 in total

1.  The effect of two moisturisers on skin barrier damage in allergic contact dermatitis.

Authors:  Jean-Pierre Hachem; Kristien De Paepe; Els Vanpee; Leonard Kaufman; Vera Rogiers; Diane Roseeuw
Journal:  Eur J Dermatol       Date:  2002 Mar-Apr       Impact factor: 3.328

2.  Moisturizers prevent irritant dermatitis.

Authors:  A Hannuksela; T Kinnunen
Journal:  Acta Derm Venereol       Date:  1992       Impact factor: 4.437

3.  Evidence-based medicine for occupational health.

Authors:  Jos H Verbeek; Frank J van Dijk; Antti Malmivaara; Carel T Hulshof; Kimmo Räsänen; Eila E Kankaanpää; Kriistina Mukala
Journal:  Scand J Work Environ Health       Date:  2002-06       Impact factor: 5.024

Review 4.  Do barrier creams and gloves prevent or provoke contact dermatitis?

Authors:  W Wigger-Alberti; P Elsner
Journal:  Am J Contact Dermat       Date:  1998-06

5.  A skin moisturizing cream containing Quaternium-18-Bentonite effectively improves chronic hand dermatitis.

Authors:  J F Fowler
Journal:  J Cutan Med Surg       Date:  2001-05-02       Impact factor: 2.092

6.  The efficacy of a protective cream in a real-world apprentice hairdresser environment.

Authors:  D Perrenoud; D Gallezot; G van Melle
Journal:  Contact Dermatitis       Date:  2001-09       Impact factor: 6.600

7.  Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers.

Authors:  R D McCormick; T L Buchman; D G Maki
Journal:  Am J Infect Control       Date:  2000-08       Impact factor: 2.918

8.  [Use of skin protective agents by patients with occupational dermatoses: need for improved preventive behavior].

Authors:  W Wigger-Alberti; B Maraffio; P Elsner
Journal:  Schweiz Med Wochenschr       Date:  1997-05-24

9.  In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents.

Authors:  G Korinth; S Geh; K H Schaller; H Drexler
Journal:  Int Arch Occup Environ Health       Date:  2003-05-09       Impact factor: 3.015

10.  The effect of 4 barrier creams on the absorption of water, benzene, and formaldehyde into excised human skin.

Authors:  M Lodén
Journal:  Contact Dermatitis       Date:  1986-05       Impact factor: 6.600

View more
  8 in total

1.  Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams.

Authors:  G Korinth; T Weiss; S Penkert; K H Schaller; J Angerer; H Drexler
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

2.  Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial.

Authors:  Robert Winker; Bayda Salameh; Sabine Stolkovich; Michael Nikl; Alfred Barth; Elisabeth Ponocny; Hans Drexler; Gerhard Tappeiner
Journal:  Int Arch Occup Environ Health       Date:  2008-10-30       Impact factor: 3.015

3.  How does working in pandemic units affect the risk of occupational hand eczema in healthcare workers during the coronavirus disease-2019 (COVID-19) pandemic: A comparative analysis with nonpandemic units.

Authors:  Yasemin Erdem; Sena Inal; Onur Sivaz; Sevkiye Copur; Kubra N Boluk; Ece Ugurer; Hazel E Kaya; Ilayda E Gulsunay; Gul Sekerlisoy; Osman Vural; Ilknur K Altunay; Aslı Aksu Çerman; Esen Özkaya
Journal:  Contact Dermatitis       Date:  2021-04-01       Impact factor: 6.419

Review 4.  Interventions for preventing occupational irritant hand dermatitis.

Authors:  Andrea Bauer; Henriette Rönsch; Peter Elsner; Daan Dittmar; Cathy Bennett; Marie-Louise A Schuttelaar; Judit Lukács; Swen Malte John; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-04-30

Review 5.  Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG.

Authors:  Jochen Brasch; Detlef Becker; Werner Aberer; Andreas Bircher; Birger Kränke; Kirsten Jung; Bernhard Przybilla; Tilo Biedermann; Thomas Werfel; Swen Malte John; Peter Elsner; Thomas Diepgen; Axel Trautmann; Hans F Merk; Thomas Fuchs; Axel Schnuch
Journal:  Allergo J Int       Date:  2014

6.  The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial.

Authors:  Maryam Soltanipoor; Sanja Kezic; Judith K Sluiter; Thomas Rustemeyer
Journal:  Trials       Date:  2017-02-28       Impact factor: 2.279

Review 7.  The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace.

Authors:  J Hines; S M Wilkinson; S M John; T L Diepgen; J English; T Rustemeyer; S Wassilew; S Kezic; H I Maibach
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-08-22       Impact factor: 6.166

8.  Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers.

Authors:  Maryam Soltanipoor; Sanja Kezic; Judith Sluiter; Rebecca Holman
Journal:  Trials       Date:  2018-08-06       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.